Cagrilintide 10mg + Semaglutide 10mg (20mg Total) is a premium research peptide blend containing two extensively studied compounds: Cagrilintide, a long-acting amylin analog, and Semaglutide, a GLP-1 receptor agonist.
Researchers investigate this peptide combination due to its complementary mechanisms of action. Cagrilintide is studied for its potential role in promoting satiety and reducing food intake, while Semaglutide is researched for its effects on glucose regulation, appetite control, and metabolic health.
The combination has gained significant attention within the scientific community for experimental studies related to:
- Appetite regulation
- Energy balance research
- Weight management studies
- Metabolic pathway investigations
- Glucose metabolism research
- Obesity-related scientific studies
Manufactured under strict quality standards, this peptide blend is intended exclusively for laboratory and research use by qualified professionals.



Reviews
There are no reviews yet.